Biogen Idec, Inc. (Massachusetts) (BIIB) Delivers Double-Digit Top & Bottom-Line Growth in Second Quarter 2013
7/25/2013 7:51:57 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Biogen Idec Inc. (NASDAQ: BIIB) today reported second quarter 2013 total revenues of $1.7 billion, an increase of 21% compared to the second quarter of 2012. Non-GAAP diluted EPS for the second quarter of 2013 were $2.30, an increase of 26% over the second quarter of 2012. Non-GAAP net income attributable to Biogen Idec for the second quarter of 2013 was $549 million, an increase of 25% versus the second quarter of 2012.
Help employers find you! Check out all the jobs and post your resume.